Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3503 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

HepaLife signs research agreement with USDA

HepaLife is incorporating the PICM-19 cell line in its developmental stage bioartificial liver. HepaLife’s bioartificial liver, designed to operate outside the patient’s body, is envisioned to mimic important